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I have always wondered how many lives EVAR has saved.
There is no question that EVAR is less invasive and can be
performed with less discomfort compared with open surgery.
However, the recent update of the EVAR and the DREAM trials
has shown that the acute benefit of EVAR is quickly lost, and that
there is no survival advantage in themid-term. In short, EVARmay
provide greater comfort, but it may not have saved more lives
compared with open surgery.
On the other hand, EVAR for ruptured AAAs has the “poten-
tial” to actually save lives. We have extensive experience in this
field, and based on my personal “level 5” evidence, I continue to
believe that EVAR is the preferred treatment for most patients with
ruptured AAAs. Evidence is growing that EVAR may be better
than open surgery for patients with ruptured AAAs, and there is a
near consensus among experts that EVAR is the only way to go for
ruptured AAAs.
The article by Gerassimidis et al is further circumstantial
evidence that supports this belief. The fact that one can treat such
patients without laparotomy, which leads to release of tamponade
and worsening of hypotension, that one does not have to deal with
difficulties associated with the hematoma obscuring the anatomy,
which may lead to iatrogenic injury of the veins, ureter and the
bowels, that one can avoid reperfusion injury and visceral ischemia,
that one can avoid hypothermia, which often exacerbates the
coagulopathy, all makes sense and therefore it is very easy to jump
to this conclusion. However, one needs to be careful in interpret-
ing this result as well as those of others that report favorable
outcomes.
The most important issue requiring attention is that of patient
selection bias. Of the 38 patients who were treated during the
study period, 40% underwent open surgery. Although it is not clear
from the article, it is possible and likely that those who were
hemodynamically unstable were treated with open repair. Since the
authors did not have a stock of endografts in the hospital, they had
to scramble and call the company representatives to get an en-
dograft as soon as possible. This setting will certainly make it
difficult—and sometimes unethical—to performEVAR in a patient
with hemodynamic instability.
Equally important is the anatomic selection bias. Naturally,
those with pararenal AAAs or with more complex anatomy were
treated with open surgery. One needs to take into account these
issues before concluding whether 39% surgical mortality reported
in this series is good or not. As the authors point out, only
multicenter randomized trials can answer this question.
The anatomic eligibility was 61% in this series. However, for
our US readership, it is important to note that Gerassimidis et alUnited States, including the Talent (Medtronic, Minneapolis,
Minn) and the EndoFit (Endomed [LeMaitre Vasculare], Burling-
ton, Mass) endografts, which were used in more than 80% of cases.
It is known that ruptured AAAs have a shorter, wider neck, and
these endografts offer stents as large as 36 mm in diameter.1 Lack
of access to such endografts will certainly impact the eligibility rate
for patients treated in the United States. Availability of these
endografts is highly and urgently needed in the United States.
This series, as well as those published previously, have all been
reported by experienced physicians at centers of excellence. Each
operator had extensive experience in endografting in the elective
setting. One needs to be familiar with various devices and also be
proficient in the deployment of each before tackling these patients
under desperate conditions in which the margin for error is much
narrower. In addition to the authors’ excellent technique, which is
reflected by the 96% technical success, it is important not to
overlook the details that contributed to their respectable result.
This includes the use of permissive hypotension originally advo-
cated by Crawford,2 preferential use of local anesthetics, availabil-
ity of a dedicated endovascular operating room , ability to perform
computed tomography scans without delay, endovascular on-call
scheduling, and training of paramedic staff. Undoubtedly, the
devil is in the details.
In my practice, I routinely place a 5F sheath in the brachial
artery under local anesthesia and keep the guidewire placed in the
descending thoracic aorta before induction of general anesthesia or
initiation of the groin cut down.3 This allows one to quickly
upgrade the sheath and deploy an aortic occlusion balloon should
it become necessary. Although balloon occlusion has only been
used in 20% of our cases, for those cases that require it, it can mean
the difference between life and death. All five patients in this series
who experienced intra-operative hypotension were lost. These
patients might have benefited from the aortic occlusion balloon,
and I believe that this technique is worthwhile considering for both
open and EVAR for ruptured AAAs.
The authors are commended for saving (probably) lives.
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